Free express shipping over $500 AUD

Individual Compound Research

AOD9604: A Laboratory Research Reference

A non-promotional scientific reference on AOD9604 — growth hormone C-terminal fragment identity, metabolic signalling as studied, molecular characteristics and analytical testing.

8 min readReviewed 26 August 2026

Quick Answer

AOD9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, studied in laboratory research for its metabolic signalling — particularly fat-mobilisation pathways — distinct from the growth-promoting activity of full-length growth hormone. It is supplied strictly for laboratory research purposes and is not a therapeutic or approved medicine.

AOD9604 is a synthetic peptide studied in metabolic research. It is a fragment derived from the C-terminal region of human growth hormone, and is investigated in laboratory settings for its metabolic activity — particularly the lipolytic (fat-mobilisation) pathways that distinguish it from full-length growth hormone.

This page is a non-promotional scientific reference for researchers. It does not provide weight-loss, fat-loss, therapeutic, or human-use guidance. AOD9604 supplied by Bulk Aussie Peptides is for laboratory research purposes only.

Chemical Identity and Origin

AOD9604 is a modified fragment of the growth hormone molecule, specifically derived from the C-terminal portion of the protein. It was developed in the research setting with the aim of isolating the metabolic effects of growth hormone from its growth-promoting effects, a goal reflected in its fragment-based design.

As a synthetic peptide, AOD9604 is assembled in the laboratory, then purified and characterised before it is supplied for research. For background on production and verification, see the synthetic peptides research guide.

Mechanism as Studied

The research literature describes AOD9604 as active in metabolic signalling related to fat mobilisation, acting through pathways distinct from the classical growth hormone receptor. This fragment-based, receptor-independent activity is a central point of research interest and the reason the compound is studied separately from full-length growth hormone. Findings remain preclinical.

Molecular Characteristics

  • Classification: a synthetic C-terminal fragment of human growth hormone.
  • Sequence basis: derived from the C-terminal region of the growth hormone protein, with a modification.
  • Molecular weight: reported in Daltons (Da) and compared against the theoretical sequence-derived mass.
  • Physical form: lyophilised (freeze-dried) powder.

Areas of Scientific Research

  • Metabolic signalling: fat-mobilisation and metabolic pathways in experimental models.
  • Growth hormone fragment biology: isolating metabolic activity from growth-promoting activity.
  • Receptor-independent activity: mechanisms distinct from the classical growth hormone receptor.

These investigations are conducted in vitro or in approved animal research models under institutional oversight.

Analytical Testing

AOD9604 is characterised using:

See how to read a peptide Certificate of Analysis for interpretation guidance.

References and Further Reading

About this page. This article is a non-promotional reference prepared by the Bulk Aussie Peptides research team for educational purposes. It is not medical advice and does not provide dosage, injection, therapeutic, or human-use guidance. Product information is for laboratory research only. How we write and review our research library · Report a correction

Related Articles

Explore the Research Library

Browse our collection of educational reference material.

View All Articles